Recent Updates
Recently added Catalysts
EWTX Positive Sentiment

Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025 Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the...

Wednesday, May 14, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Edgewise Therapeutics, Inc. will present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025. The presentation is scheduled for 9:00 am ET and will be available via a live webcast, allowing for broader access to interested parties. This participation highlights the company's ongoing commitment to addressing muscle diseases and enhances its visibility within the biopharmaceutical industry.
Price reaction · baseline $14.89 (2025-05-13 close) · hit after-hours · clean, no other EWTX news in the window
day 0 close · peak
-2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Management is presenting at a notable healthcare conference.
  • Live webcasting increases accessibility for stakeholders.
  • The company is promoting its presence in the muscle disease sector.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
5.6%
average across 5 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
EDG-7500
Phase 2 · Hypertrophic Cardiomyopathy

Full Press Release Details

BOULDER, Colo. , May 14, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX ), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025 , at 9:00 am ET .
The presentation will be webcast live; a link for the webcast can be found on the Edgewise Events & Presentations page and will be accessible for replay, for a limited time, following the conference. It is recommended that users connect to the live webcast several minutes prior to the start to ensure a timely connection.
About Edgewise Therapeutics

Frequently Asked Questions

When is Edgewise Therapeutics' presentation at the RBC Conference?

The presentation is on May 20, 2025, at 9:00 am ET.

Where can I watch the Edgewise presentation live?

The presentation will be webcast live on the Edgewise Events & Presentations page.

How can I access the presentation replay?

The replay will be available for a limited time after the conference.

What should I do before the live webcast starts?

It’s best to connect several minutes early to ensure a timely connection.

ShareAdd on Google
Tags: EWTX Viatris Investor Conferences Healthcare Edgewise Therapeutics muscle disease healthcare conference RBC Capital Markets
Last updated: May 14, 2025

Biotech snapshot

Cash runway
$72M liquidity · $14M/mo burn
~5 mo
High dilution risk
Lead asset
EDG-7500Phase 2
Hypertrophic Cardiomyopathy →

Catalyst track record

+111%
best trade around EWTX's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for EWTX.

See every catalyst's timing & PoA →